{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:42:01Z","timestamp":1770702121885,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1038\/nm0398-315","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T01:57:35Z","timestamp":1092880655000},"page":"315-320","source":"Crossref","is-referenced-by-count":72,"title":["MUC1 cross-reactive Gal\u03b1(l,3)Gal antibodies in humans switch immune responses from cellular to humoral"],"prefix":"10.1038","volume":"4","author":[{"given":"Vasso","family":"Apostolopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Osinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian F.C.","family":"Mckenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnm0398315_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/jnci\/86.5.330","volume":"86","author":"A Singer","year":"1994","unstructured":"Singer, A., Time and truth for cancer vaccines\u2014a new generation. J. Natl. Cancer Inst. 86, 330\u2013330 (1994).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFnm0398315_CR2","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1073\/pnas.91.9.3515","volume":"91","author":"Y Kawakami","year":"1994","unstructured":"Kawakami, Y. et al. Cloning of the gene coding for a shared human-melanoma anti-gen recognized by autologous T-cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91, 3515\u20133519 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0398315_CR3","first-page":"1071","volume":"54","author":"ML Disis","year":"1994","unstructured":"Disis, M.L., Smith, J.W., Murphy, A.E., Chen, W., & Cheever, M.A. In vitro generation of human CTL specific for peptides derived from the Her-2\/neu protooncogene pro-tein. Cancer Res. 54, 1071\u20131076 (1994).","journal-title":"Cancer Res."},{"key":"BFnm0398315_CR4","doi-asserted-by":"publisher","first-page":"11993","DOI":"10.1073\/pnas.92.26.11993","volume":"92","author":"M Theobald","year":"1995","unstructured":"Theobald, M., Biggs, J., Dittmer, D., Levine, A.J. & Sherman, L.A. Targeting p53 as a general tumor antigen. Proc. Natl. Acad. Sci. USA 92, 11993\u201311997 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0398315_CR5","first-page":"4020","volume":"53","author":"DJ Schendel","year":"1993","unstructured":"Schendel, D.J. & Gansbacher, B. Tumor specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: Modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment. Cancer Res. 53, 4020\u20134025 (1993).","journal-title":"Cancer Res."},{"key":"BFnm0398315_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/icb.1996.76","volume":"74","author":"V Apostolopoulos","year":"1996","unstructured":"Apostolopoulos, V., McKenzie, I.F.C. & Pietersz, G.A. Breast cancer immunother-apy\u2014Current status and future prospects. Immunol. Cell Biol. 74, 457\u2013464 (1996).","journal-title":"Immunol. Cell Biol."},{"key":"BFnm0398315_CR7","first-page":"5186","volume":"54","author":"V Apostolopoulos","year":"1994","unstructured":"Apostolopoulos, V., Xing, P.X. & McKenzie, I.F.C. Murine immune response to cells transfected with human MUC1: Immunization with cellular and synthetic antigens. Cancer Res. 54, 5186\u20135193 (1994).","journal-title":"Cancer Res."},{"key":"BFnm0398315_CR8","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/0264-410X(95)00258-3","volume":"14","author":"V Apostolopoulos","year":"1996","unstructured":"Apostolopoulos, V., Pietersz, G.A. & McKenzie, I.F.C. Cell-mediated immune re-sponses to MUC1 fusion protein coupled to mannan. Vaccine 14, 930\u2013938 (1996).","journal-title":"Vaccine"},{"key":"BFnm0398315_CR9","doi-asserted-by":"publisher","first-page":"10128","DOI":"10.1073\/pnas.92.22.10128","volume":"92","author":"V Apostolopoulos","year":"1995","unstructured":"Apostolopoulos, V., Pietersz, G.A., Loveland, B.E., Sandrin, M.S. & McKenzie, I.F.C. Oxidative\/reductive conjugation of mannan to antigen selects for T, or T2 immune responses. Proc. Natl. Acad. Sci. USA 92, 10128\u201310132 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0398315_CR10","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1172\/JCI119825","volume":"100","author":"V Karanikas","year":"1997","unstructured":"Karanikas, V. et al. Antibody and T cell responses of patients with adenocarcinoma im-munized with mannan-MUCI fusion protein. J. Clin. Invest. 100, 2738\u20132792 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFnm0398315_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1399-3089.1996.tb00114.x","volume":"3","author":"HA Vaughan","year":"1996","unstructured":"Vaughan, H.A. et al. Recognition of an octapeptide sequence by multiple Gal\u03b1(1,3)Gal-binding proteins. Xenotransplantation 3, 18\u201323 (1996).","journal-title":"Xenotransplantation"},{"key":"BFnm0398315_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1023\/A:1018521217276","volume":"14","author":"MS Sandrin","year":"1997","unstructured":"Sandrin, M.S., Vaughan, H.A., Xing, P.X. & McKenzie, I.F.C. Natural human anti-Gal\u03b1(1,3)Gal antibodies react with human mucin peptides. Glycoconj. J. 14, 97\u2013105 (1997).","journal-title":"Glycoconj. J."},{"key":"BFnm0398315_CR13","doi-asserted-by":"publisher","first-page":"11391","DOI":"10.1073\/pnas.90.23.11391","volume":"90","author":"MS Sandrin","year":"1995","unstructured":"Sandrin, M.S., Vaughan, H.A., Dabkowski, P.L. & McKenzie, I.F.C. Anti-pig antibodies in human serum predominantly with Gal\u03b1(1,3)Gal epitopes. Proc. Natl. Acad. Sci. USA 90, 11391\u201311395 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0398315_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/00007890-199410270-00003","volume":"58","author":"HA Vaughan","year":"1994","unstructured":"Vaughan, H.A., Loveland, B.E. & Sandrin, M.S. Gal\u03b1(1,3)Gal is the major xenoepitope expressed on pig endothelial cells recognised by naturally occurring cytotoxic anti-bodies. Transplantation 58, 879\u2013884 (1994).","journal-title":"Transplantation"},{"key":"BFnm0398315_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0966-3274(94)90032-9","volume":"2","author":"IFC McKenzie","year":"1994","unstructured":"McKenzie, I.F.C. et al. Distribution of the major xenoantigens (Gal\u03b1(1,3)Gal) for pig to human xenografts. Transplant Immunol. 2, 81\u201386 (1994).","journal-title":"Transplant Immunol."},{"key":"BFnm0398315_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0167-5699(97)80024-2","volume":"18","author":"U Galili","year":"1997","unstructured":"Galili, U. & La Temple, C. Natural anti-Gal antibody as a universal augmentor of au-tologous tumor vaccine immunogenicity. Immunol. Today 18, 281\u2013285 (1997).","journal-title":"Immunol. Today"},{"key":"BFnm0398315_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/hep.1840070324","volume":"7","author":"E Celis","year":"1987","unstructured":"Celis, E., Abraham, K.G. & Miller, R.W. Modulation of the immunological response to hepatitis B virus by antibodies. Hepatology 7, 563\u2013568 (1987).","journal-title":"Hepatology"},{"issue":"5065","key":"BFnm0398315_CR18","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1126\/science.1535455","volume":"256","author":"S Amigorena","year":"1992","unstructured":"Amigorena, S. et al. Cytoplasmic domain heterogeneity and functions of IgG Fc re-ceptors in B lymphocytes. Science 256,1801 1812 (1992).","journal-title":"Science"},{"key":"BFnm0398315_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1574-695X.1996.tb00218.x","volume":"13","author":"P Bouige","year":"1996","unstructured":"Bouige, P., Iscaki, S., Cosson, A. & Pillot, J. Molecular analysis of the modulatory fac-tors of the response to HBsAg in mice as an approach to HBV vaccine enhancement. Immunol. Med. Microbiol. 13, 71\u201379 (1996).","journal-title":"Immunol. Med. Microbiol."},{"key":"BFnm0398315_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1172\/JCI118420","volume":"97","author":"IA Heijnen","year":"1996","unstructured":"Heijnen, I.A. et al. Antigen targeting to myeloid-specific human Fc gamma RI\/CD64 triggers enhanced antibody responses in transgenic mice. J. Clin. Invest. 97, 331\u2013338 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFnm0398315_CR21","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1073\/pnas.93.8.3357","volume":"93","author":"H Molina","year":"1996","unstructured":"Molina, H. et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93, 3357\u20133361 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0398315_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0167-5699(84)90137-3","volume":"5","author":"I Lefkovits","year":"1984","unstructured":"Lefkovits, I. & Waldmann, H. Limiting dilution analysis of the cells of the immune sys-tem. I. The clonal basis of the immune response. Immunol. Today 5, 265\u2013272 (1984).","journal-title":"Immunol. Today"},{"key":"BFnm0398315_CR23","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.4049\/jimmunol.126.4.1614","volume":"126","author":"C Taswell","year":"1981","unstructured":"Taswell, C. Limiting dilution assays for the determination of immunocompetent cell frequencies. J. Immunol. 126, 1614\u20131619 (1981).","journal-title":"J. Immunol."},{"key":"BFnm0398315_CR24","doi-asserted-by":"crossref","unstructured":"Fazekas de St. Groth, S. The evaluation of limiting dilution assays [review]. J. Immunol. Methods 49, R11R23 (1982).","DOI":"10.1016\/0022-1759(82)90269-1"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0398-315","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0398-315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0398-315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:12:14Z","timestamp":1684447934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0398-315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["BFnm0398315"],"URL":"https:\/\/doi.org\/10.1038\/nm0398-315","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}